These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28927802)

  • 21. Noninvasive quantitative evaluation of viable islet grafts using
    Botagarova A; Murakami T; Fujimoto H; Fauzi M; Kiyobayashi S; Otani D; Fujimoto N; Inagaki N
    FASEB J; 2023 Apr; 37(4):e22859. PubMed ID: 36906290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers.
    Rylova SN; Waser B; Del Pozzo L; Tönnesmann R; Mansi R; Meyer PT; Reubi JC; Maecke HR
    J Nucl Med; 2016 Aug; 57(8):1282-8. PubMed ID: 27127218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A standardized method for in vivo mouse pancreas imaging and semiquantitative β cell mass measurement by dual isotope SPECT.
    Mathijs I; Xavier C; Peleman C; Caveliers V; Brom M; Gotthardt M; Herrera PL; Lahoutte T; Bouwens L
    Mol Imaging Biol; 2015 Feb; 17(1):58-66. PubMed ID: 25070262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
    Christ E; Wild D; Ederer S; Béhé M; Nicolas G; Caplin ME; Brändle M; Clerici T; Fischli S; Stettler C; Ell PJ; Seufert J; Gloor B; Perren A; Reubi JC; Forrer F
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):115-22. PubMed ID: 24622317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation effect of imeglimin on pancreatic β-cell mass: Noninvasive evaluation using
    Fauzi M; Murakami T; Fujimoto H; Botagarova A; Sakaki K; Kiyobayashi S; Ogura M; Inagaki N
    Front Endocrinol (Lausanne); 2022; 13():1010825. PubMed ID: 36246910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
    Brom M; Oyen WJ; Joosten L; Gotthardt M; Boerman OC
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1345-55. PubMed ID: 20111963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of novel radioiodinated exendin-4 derivatives targeting GLP-1 receptor for detection of β-cell mass.
    Ogawa Y; Kimura H; Fujimoto H; Kawashima H; Toyoda K; Mukai E; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2021 Dec; 52():116496. PubMed ID: 34808404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a method for in-vivo SPECT/CT imaging analysis of
    Hamamatsu K; Fujimoto H; Fujita N; Murakami T; Kimura H; Saji H; Inagaki N
    Nucl Med Biol; 2018; 64-65():22-27. PubMed ID: 30015092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
    Zhang B; Yang B; Zhai C; Jiang B; Wu Y
    Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas.
    Brom M; Joosten L; Oyen WJ; Gotthardt M; Boerman OC
    Contrast Media Mol Imaging; 2012; 7(2):160-6. PubMed ID: 22434628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of
    Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
    Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive in vivo determination of viable islet graft volume by
    Eter WA; Van der Kroon I; Andralojc K; Buitinga M; Willekens SMA; Frielink C; Bos D; Joosten L; Boerman OC; Brom M; Gotthardt M
    Sci Rep; 2017 Aug; 7(1):7232. PubMed ID: 28775287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin.
    Willekens SM; Joosten L; Boerman OC; Balhuizen A; Eizirik DL; Gotthardt M; Brom M
    Mol Imaging Biol; 2016 Oct; 18(5):705-14. PubMed ID: 26886298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Activity Relationships and Pharmacokinetics of
    Iikuni S; Ohara T; Watanabe H; Ono M
    Mol Pharm; 2022 Aug; 19(8):2832-2839. PubMed ID: 35757958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.